ARCA biopharma, Inc. (ABIO)

NASDAQ: ABIO · IEX Real-Time Price · USD
2.46
-0.07 (-2.77%)
At close: Jun 24, 2022 4:00 PM
2.53
+0.07 (2.85%)
After-hours: Jun 24, 2022 7:38 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 1994
Selling, General & Admin
5.54.773.983.884.644.274.394.074.013.23
Upgrade
Research & Development
13.834.991.834.2414.0812.357.065.632.931.09
Upgrade
Operating Expenses
19.349.775.818.1218.7116.6111.469.696.944.32
Upgrade
Operating Income
-19.34-9.77-5.81-8.12-18.71-16.61-11.46-9.69-6.94-4.32
Upgrade
Interest Expense / Income
00.010.010.010.0100000
Upgrade
Other Expense / Income
-0.01-0.03-0.17-0.16-0.17-0.17-0.01-0.01-0.01-0
Upgrade
Pretax Income
-19.32-9.75-5.65-7.96-18.55-16.44-11.45-9.69-6.94-4.32
Upgrade
Income Tax
0-0.01-0.17-0.03-0.0600000
Upgrade
Net Income
-19.32-9.74-5.48-7.93-18.49-16.44-11.45-9.69-6.94-4.32
Upgrade
Preferred Dividends
000000002.030
Upgrade
Net Income Common
-19.32-9.74-5.48-7.93-18.49-16.44-11.45-9.69-8.97-4.32
Upgrade
Shares Outstanding (Basic)
14511110000
Upgrade
Shares Outstanding (Diluted)
14511110000
Upgrade
Shares Change
195.18%256.50%71.72%32.76%15.04%44.17%114.74%137.57%288.10%32.90%
Upgrade
EPS (Basic)
-1.39-2.07-4.15-10.31-31.86-32.58-32.76-59.58-131.04-244.44
Upgrade
EPS (Diluted)
-1.39-2.07-4.15-10.31-31.86-32.58-32.76-59.58-131.04-244.44
Upgrade
Free Cash Flow Per Share
-1.35-1.64-3.64-10.72-30.15-29.77-30.18-57.93-77.68-231.09
Upgrade
Effective Tax Rate
0.00%0.09%2.96%0.39%0.33%0.00%0.00%0.00%0.00%0.00%
Upgrade
EBITDA
-19.23-9.65-5.55-7.93-18.19-16.12-11.23-9.61-6.91-4.27
Upgrade
Depreciation & Amortization
0.090.090.090.020.360.320.210.080.030.04
Upgrade
EBIT
-19.32-9.74-5.64-7.96-18.55-16.44-11.44-9.69-6.94-4.32
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).